Abstract

The crystal structure of form 4 of the drug 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid is determined using a protocol for NMR powder crystallography at natural isotopic abundance combining solid-state (1)H NMR spectroscopy, crystal structure prediction, and density functional theory chemical shift calculations. This is the first example of NMR crystal structure determination for a molecular compound of previously unknown structure, and at 422 g/mol this is the largest compound to which this method has been applied so far.

Keywords

ChemistryCrystal structureNuclear magnetic resonance crystallographyMoleculeCrystallographyNuclear magnetic resonance spectroscopyBenzoic acidCrystal structure predictionCrystal (programming language)Density functional theoryCarbon-13 NMR satelliteTransverse relaxation-optimized spectroscopyCarbon-13 NMRChemical shiftSpectroscopyFluorine-19 NMRStereochemistryComputational chemistryPhysical chemistryOrganic chemistry

Affiliated Institutions

Related Publications

Publication Info

Year
2013
Type
article
Volume
135
Issue
46
Pages
17501-17507
Citations
206
Access
Closed

External Links

Citation Metrics

206
OpenAlex

Cite This

Maria Baias, Jean‐Nicolas Dumez, Per H. Svensson et al. (2013). <i>De Novo</i> Determination of the Crystal Structure of a Large Drug Molecule by Crystal Structure Prediction-Based Powder NMR Crystallography. Journal of the American Chemical Society , 135 (46) , 17501-17507. https://doi.org/10.1021/ja4088874

Identifiers

DOI
10.1021/ja4088874